Outset Medical Inc Ordinary Shares OM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OM is a good fit for your portfolio.
News
-
Outset Medical Reports First Quarter 2024 Financial Results
-
Outset Medical Shares Rise 56% After FDA Grants Clearance for TabloCart
-
Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
-
Outset Medical to Present at Upcoming Investor Conferences
-
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
-
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
-
Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
-
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
Trading Information
- Previous Close Price
- $3.27
- Day Range
- $2.93–3.27
- 52-Week Range
- $1.92–24.13
- Bid/Ask
- $2.93 / $3.25
- Market Cap
- $158.73 Mil
- Volume/Avg
- 1.4 Mil / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.23
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 480
- Website
- https://www.outsetmedical.com
Comparables
Valuation
Metric
|
OM
|
MMSI
|
AKT
|
---|---|---|---|
Price/Earnings (Normalized) | — | 25.74 | — |
Price/Book Value | 1.70 | 3.79 | 6.96 |
Price/Sales | 1.23 | 3.68 | 6.41 |
Price/Cash Flow | — | 20.70 | — |
Price/Earnings
OM
MMSI
AKT
Financial Strength
Metric
|
OM
|
MMSI
|
AKT
|
---|---|---|---|
Quick Ratio | 4.27 | 4.22 | 0.74 |
Current Ratio | 5.26 | 6.03 | 0.81 |
Interest Coverage | −13.39 | 6.17 | 11.08 |
Quick Ratio
OM
MMSI
AKT
Profitability
Metric
|
OM
|
MMSI
|
AKT
|
---|---|---|---|
Return on Assets (Normalized) | −38.44% | 9.17% | 5.43% |
Return on Equity (Normalized) | −83.38% | 15.14% | 14.42% |
Return on Invested Capital (Normalized) | −43.78% | 10.93% | 10.12% |
Return on Assets
OM
MMSI
AKT
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Wwqyrwmh | Sffsz | $182.6 Bil | |
SYK
| Stryker Corp | Ysfxfqvsyt | Lyh | $125.9 Bil | |
MDT
| Medtronic PLC | Czwpcvn | Ylhwyph | $108.3 Bil | |
BSX
| Boston Scientific Corp | Sbqlzsbx | Sfsqfz | $106.9 Bil | |
EW
| Edwards Lifesciences Corp | Wbkjhfvwq | Crtzxl | $52.3 Bil | |
DXCM
| DexCom Inc | Mptrrgyr | Xmccy | $50.3 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qbgkqbqcpt | Vlr | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Prpbnjsn | Tksxw | $24.3 Bil | |
ALGN
| Align Technology Inc | Csncjqg | Gwpxgyg | $21.1 Bil | |
PODD
| Insulet Corp | Lqzpfsqcd | Yrdgvx | $12.4 Bil |